Year None2021202020192018201720162015201420132012 05.01.2018 Ophthotech Completes Patient Recruitment in the Phase 2a Clinical Trial of Zimura® in Combination with Anti-VEGF Therapy in Wet Age-Related Macular Degeneration 05.01.2018 Ophthotech Corporation to Report First Quarter 2018 Financial Results and Host Conference Call on Wednesday, May 9, 2018 03.06.2018 Ophthotech to Present at the Cowen and Company 38th Annual Health Care Conference 02.27.2018 Ophthotech Reports Fourth Quarter and Full Year 2017 Financial and Operating Results 02.27.2018 Ophthotech Targets Gene Therapy to Expand its Orphan and Age-Related Retinal Disease Strategy 02.21.2018 Ophthotech Corporation to Report Fourth Quarter and Full Year 2017 Financial Results and Host Conference Call on Tuesday, February 27, 2018 01.16.2018 Ophthotech Announces First Patient Enrolled in the Phase 2b Clinical Trial of Zimura®, Complement C5 Inhibitor, for the Treatment of Autosomal Recessive Stargardt Disease (STGD1) 01.16.2018 Ophthotech Announces Election of Jane Pritchett Henderson, Chief Financial Officer and Senior Vice President of Corporate Development at Voyager Therapeutics, to Its Board of Directors 01.02.2018 Ophthotech Corporation to Present at the 36th Annual J.P. Morgan Healthcare Conference 11.08.2017 Ophthotech Reports Third Quarter 2017 Financial and Operating Results Pagination First page « first Previous page ‹ previous … Page 5 Page 6 Page 7 Page 8 Current page 9 Page 10 Page 11 Page 12 Page 13 … Next page next › Last page last »
